| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |